• +660 9238 93971
  • yanliangjie@gmail.com
Does Egg Quality Always Decline After 35? Research Finds Another Hidden Factor in Ovarian Aging

Does Egg Quality Always Decline After 35? Research Finds Another Hidden Factor in Ovarian Aging

Published: 2026-10-02 |Views: 9595

Does Egg Quality Always Decline After 35? Research Finds Another Hidden Factor in Ovarian Aging

For women preparing for pregnancy, 35 often seems to be an important age threshold. Some begin worrying about declining egg quality just after turning 35; others have favorable AMH and basal follicle counts but encounter suboptimal embryo development during IVF treatment.

Why do women of similar age and ovarian reserve sometimes end up with clearly different egg and embryo quality?

In fact, female reproductive aging involves not only a decline in egg number but also complex processes such as cellular energy metabolism, oxidative stress, and DNA damage repair.

In recent years, reproductive medicine research has begun to focus on a structure closely related to cellular aging—telomeres. Studies have found that telomere changes may reflect some of the damage experienced by ovarian cells, offering a new research clue for understanding declining egg quality.

Today, Global New Life starts from relevant research to help readers understand the relationship between telomeres and ovarian aging, and which health management measures deserve attention before preparing for IVF or third-generation IVF treatment in Thailand.

1. Is Declining Egg Quality Really Determined Entirely by Age?

Age is an important factor affecting female fertility. As age increases, the number of remaining follicles in the ovaries gradually decreases, and the risk of chromosomal abnormalities in oocytes also increases. Especially after 35, the downward trend in fertility may be more pronounced in some women.

However, turning 35 does not mean that egg quality will suddenly decline precipitously.

Even at the same age, women may differ in ovarian reserve, genetic background, metabolic status, and previous health conditions, so they may show notable differences in response to ovarian stimulation, number of mature eggs, and embryo development.

One marker deserves particular attention here: anti-Müllerian hormone (AMH).

AMH is mainly used to help assess ovarian reserve and predict response to ovarian stimulation. It cannot directly determine the chromosomal status of oocytes, nor can it alone predict the final live birth rate of IVF.

In other words, a normal AMH level does not mean that every egg has good developmental potential.

In recent years, researchers have tried to find further explanations in cellular aging mechanisms, and one structure that has attracted attention is the telomere at the ends of chromosomes.

2. What Are Telomeres, and Why Are They Related to Ovarian Aging?

Telomeres are located at the ends of chromosomes and consist of specific repetitive DNA sequences and associated proteins. Their main role is to maintain chromosome structural stability and protect genetic information.

In many somatic cells, telomeres may gradually shorten as cells continue to divide. When telomeres become too short or their protective function is impaired, cells may initiate a DNA damage response, leading to senescence or proliferative arrest.

However, telomere length is not the only criterion for judging cellular aging, and the patterns of change differ among cell types.

Notably, telomeres are relatively sensitive to oxidative damage.

Normal human metabolism produces a certain amount of reactive oxygen species (ROS). In appropriate amounts, ROS participate in normal cell signaling; however, when produced in excess and exceeding the body's antioxidant defense capacity, oxidative stress may occur.

Persistent oxidative stress may damage DNA, proteins, and cell membranes, and specific sequences in telomeric DNA are also susceptible to oxidative attack.

A review published in the International Journal of Molecular Sciences in 2025 discussed the potential link between oxidative stress and abnormal telomere function, proposing that this mechanism may be involved in granulosa cell aging, changes in mitochondrial function, and meiotic abnormalities in oocytes.

However, these findings are primarily mechanistic research, and telomere length cannot currently be used to directly determine a woman's egg quality.

3. Granulosa Cells Around the Egg May Hold Clues to Aging

Oocytes do not develop independently.

In the follicle, there are many granulosa cells and cumulus cells around the oocyte. They participate in nutrient exchange, hormone synthesis, and cell signaling, providing important support for oocyte maturation.

If granulosa cells develop significant mitochondrial dysfunction, oxidative damage, or cellular senescence, their ability to support normal oocyte development may also be affected.

In recent years, some studies have found that with increasing female age, telomere length, telomerase-related expression, and DNA damage markers in granulosa cells may change.

A study published in Molecular Medicine Reports in 2023 compared granulosa cells from women aged 35 and under with those from women over 35.

The study found that granulosa cell telomeres were relatively shorter in the older group, but the expression level of telomerase reverse transcriptase (TERT) was actually higher.

This may mean that when cells face telomere damage, they initiate a certain compensatory response in an attempt to maintain chromosome-end stability.

However, this compensation does not mean that cells return to a younger state, nor does it prove that ovarian aging can be reversed.

The study also observed a negative correlation between TERT expression levels and the number of eggs retrieved, but no clear association was found with blastocyst formation rate or clinical pregnancy rate.

Therefore, changes in granulosa cell telomeres may help us understand mechanisms of ovarian aging, but they cannot directly predict whether a particular IVF treatment will succeed.

At present, granulosa cell telomere testing remains a research area and is not a routine test for preconception care or assisted reproduction.

4. Can Long-Term Stress and Oxidative Stress Accelerate Ovarian Aging?

In addition to age, long-term psychological stress, insufficient sleep, metabolic abnormalities, and certain environmental exposures may also affect the body's oxidative stress levels.

A study published in PNAS in 2004 by Epel et al. found noteworthy changes in telomere length and telomerase activity in peripheral blood immune cells among women with higher levels of perceived long-term stress.

This finding suggests that persistent psychological stress may be related to certain cellular aging markers.

It should be noted, however, that the study examined peripheral blood immune cells, not the ovaries or oocytes directly.

Therefore, it cannot be concluded from this that high stress directly causes declining egg quality, and certainly not that brief anxiety, insomnia, or low mood will cause embryo implantation failure.

From a physiological perspective, long-term stress may affect neuroendocrine regulation and interact with sleep disorders, inflammatory responses, and metabolic abnormalities.

At the same time, persistent oxidative stress may affect cellular mitochondrial function and DNA stability.

For the ovary, whether these changes further affect granulosa cell function and oocyte maturation remains an important direction of current research.

What truly deserves attention is not requiring women preparing for pregnancy to maintain a good mood at all times, but reducing as much as possible the physical burden caused by long-term unhealthy lifestyle habits and clear health problems.

5. Are Antioxidant Supplements Really Useful for Improving Egg Quality?

As the relationship between oxidative stress and reproductive health attracts attention, coenzyme Q10, vitamin C, vitamin E, and other antioxidant supplements have also become topics of discussion among many women preparing for pregnancy.

Some laboratory and animal studies suggest that certain antioxidant substances may affect cellular oxidative damage, mitochondrial function, and reproduction-related markers.

For example, in some mouse studies, N-acetylcysteine (NAC) intervention was associated with changes in ovarian telomere-related markers and reproductive performance.

However, animal study results cannot be used directly to guide human treatment.

At present, there is insufficient human clinical evidence to prove that taking any single oral antioxidant can reliably lengthen ovarian cell telomeres, reverse ovarian aging, or generally improve IVF live birth rates.

Even if certain nutritional supplements show potential benefits in specific patient groups, their suitable populations, effectiveness, and long-term safety still need further confirmation.

Therefore, for women preparing for third-generation IVF in Thailand, it is not recommended to take multiple high-dose antioxidant supplements on their own over the long term in order to improve egg quality.

Rather than supplementing nutrients blindly, greater attention should be paid to standardized assessment of ovarian function, identification of clear metabolic abnormalities, nutritional deficiencies, or other health problems, and management under a doctor's guidance.

6. Preparing for Pregnancy After 35: Four Steps That Matter More

Although age cannot be changed, some lifestyle and health risk factors can be improved through informed management.

1. Maintain Regular Sleep and Reduce Habitual Late Nights

Long-term insufficient sleep and circadian rhythm disruption may affect endocrine function, glucose metabolism, and overall health.

It is advisable to keep bedtime and wake-up times as consistent as possible and reduce frequent day-night reversal. However, there is currently no evidence that simply going to bed early can repair ovarian telomeres.

2. Exercise Appropriately to Improve Metabolism

Regular exercise can help improve insulin sensitivity, cardiorespiratory fitness, and body composition.

For women without exercise contraindications, it is reasonable to gradually build up to about 150 minutes of moderate-intensity aerobic exercise per week, combined with appropriate strength training.

After entering an ovarian stimulation cycle, exercise intensity should be adjusted according to ovarian response and the doctor's advice, avoiding vigorous jumping and high-impact exercise.

3. Manage Long-Term Stress and Reduce Psychological Strain

Long-term attempts to conceive and assisted reproductive treatment can impose a significant psychological burden.

Appropriate breathing exercises, mindfulness practice, partner support, and professional psychological counseling may help improve anxiety and quality of life.

However, psychological management cannot replace medical treatment, and treatment failure should not be blamed on a patient's emotions.

4. Pay Attention to Chronic Diseases and Environmental Exposures

Abnormal glucose metabolism, smoking, long-term heavy alcohol consumption, and certain occupational chemical exposures may all have adverse effects on overall health and reproductive function.

If diabetes, thyroid disease, or other chronic diseases are present, preconception management should be carried out under a doctor's guidance.

These measures cannot guarantee a significant improvement in egg quality, but they can help reduce modifiable health risks and build a better physical foundation for subsequent pregnancy.

7. Preparing for Third-Generation IVF in Thailand: How Should Ovarian Status Be Assessed?

For families planning to travel to Thailand for assisted reproductive treatment through overseas fertility care and cross-border maternity-related medical services, understanding the mechanisms of ovarian aging is important. However, before treatment begins, assessment still needs to rely on well-established clinical tests.

Doctors usually consider the woman's age, AMH, basal antral follicle count (AFC), menstrual status, and previous treatment records to evaluate ovarian reserve and expected response to ovarian stimulation.

If the patient has previously undergone IVF treatment, a comprehensive analysis should also include the number of eggs retrieved, the proportion of mature eggs, normal fertilization, blastocyst formation, and previous pregnancy outcomes.

For older women, the risk of oocyte chromosomal abnormalities increases with age and is one of the important factors affecting reproductive outcomes.

Preimplantation genetic testing (PGT), which may be involved in third-generation IVF in Thailand, can provide specific genetic information when medical indications are met, but it cannot improve the quality of the eggs themselves, nor can it guarantee that every embryo transfer will succeed.

Therefore, for women over 35, women with diminished ovarian reserve, or those with a history of failed assisted reproductive treatment, the timing of treatment deserves greater attention. They should avoid delaying treatment for a long time in pursuit of some unproven anti-aging method.

In the process of cross-border medical care, thorough preparation of medical documents and clear communication are equally important.

Global New Life focuses on services related to assisted reproduction in Thailand. Based on the practical needs of families seeking fertility care overseas, we provide overseas medical accompaniment support such as hospital appointment coordination, medical document organization, interpretation and accompaniment during medical visits, transfer arrangements, accommodation guidance, and coordination of the medical care process.

For clients with diminished ovarian reserve, poor response to previous ovarian stimulation, or a history of repeated treatment, we assist in organizing relevant medical documents, help clients accurately explain their previous situation during consultations, and help them understand doctors' recommendations and follow-up treatment arrangements in a timely manner.

It should be emphasized that ovarian function assessment, ovarian stimulation protocols, embryo culture, genetic testing, and transfer decisions should all be made by appropriately qualified medical professionals.

Global New Life's service focus is to provide effective communication and coordination throughout the cross-border medical process, making treatment in Thailand clearer and more organized.

Conclusion: Age Cannot Be Changed, but Informed Management Still Matters

Changes in female fertility are a complex process involving ovarian reserve, oocyte development, chromosomal stability, and overall health status.

Research on telomeres and granulosa cell aging offers a new direction for understanding biological changes in the ovary and highlights that reproductive health is not only related to age but also involves the cellular microenvironment and multiple metabolic processes.

At this stage, however, telomere length still cannot serve as a routine clinical indicator for judging egg quality or predicting IVF success rates, and there is no reliable method to reverse ovarian aging through simple nutritional supplementation.

For families who are preparing for pregnancy or considering third-generation IVF in Thailand, what truly matters is completing a standardized fertility assessment in a timely manner, identifying health problems that require intervention, and developing a reasonable treatment plan based on age and physical condition.

Global New Life consistently adheres to a full-cycle fertility management approach. Through professional interpretation and medical accompaniment and cross-border medical coordination, we provide clearer and more organized service support for families traveling to Thailand for fertility care.

Age cannot be turned back, but informed assessment and reasonable planning can help us make better use of fertility opportunities.

Global New Life | Full-Cycle Fertility Management

Reminder: This article is intended only for reproductive health education and does not constitute individualized medical advice. Research on telomeres and ovarian aging is still exploratory, and laboratory mechanisms cannot be directly equated with clinical treatment effects. For specific examinations and assisted reproductive treatment plans, please follow the guidance of a professional reproductive physician.